DGX Quest Diagnostics Inc
- Stocks
- Healthcare
- NYSE: DGX
Price (delayed)
$178.26
Market cap
$19.83B
P/E Ratio
20.63
Dividend/share
$3.15
EPS
$8.64
Enterprise value
$25.78B
Relative Growth:
Rel. Growth:
56
Relative Strength:
Rel. Strength:
57
Relative Valuation:
Rel. Valuation:
69
Relative Profitability:
Rel. Profitability:
69
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals
Highlights
The gross profit has increased by 16% YoY and by 4% from the previous quarter
DGX's EPS is up by 15% year-on-year and by 2% since the previous quarter
Quest Diagnostics's quick ratio has decreased by 14% YoY but it has increased by 2.3% QoQ
DGX's price to earnings (P/E) is 31% higher than its 5-year quarterly average of 15.8
Key stats
What are the main financial stats of DGX
Market
Valuations
Earnings
Shares outstanding
111.24M
Market cap
$19.83B
Enterprise value
$25.78B
Price to earnings (P/E)
20.63
Price to book (P/B)
2.75
Price to sales (P/S)
1.84
PEG
1.38
EV/EBIT
16.79
EV/EBITDA
12.31
EV/Sales
2.38
Revenue
$10.85B
Gross profit
$3.61B
Operating income
$1.53B
Net income
$969M
EBIT
$1.54B
EBITDA
$2.1B
Free cash flow
$1.39B
Per share
Balance sheet
Liquidity
EPS
$8.64
EPS diluted
$8.52
Free cash flow per share
$12.44
Book value per share
$64.91
Revenue per share
$96.88
TBVPS
$50.3
Total assets
$16.2B
Total liabilities
$8.9B
Debt
$6.38B
Equity
$7.26B
Working capital
$273M
Debt to equity
0.88
Current ratio
1.13
Quick ratio
0.88
Net debt/EBITDA
2.84
Margins
Efficiency
Dividend
EBITDA margin
19.3%
Gross margin
33.3%
Net margin
8.9%
Operating margin
14.1%
Return on assets
6%
Return on equity
13.7%
Return on invested capital
15.8%
Return on capital employed
10.9%
Return on sales
14.1%
Dividend yield
1.77%
DPS
$3.15
Payout ratio
36.5%
DGX stock price
How has the Quest Diagnostics stock price performed over time
Intraday
0.13%
1 week
1.99%
1 month
-0.6%
1 year
15.68%
YTD
18.16%
QTD
-6.46%
Financial performance
How have Quest Diagnostics's revenue and profit performed over time
Revenue
$10.85B
Gross profit
$3.61B
Operating income
$1.53B
Net income
$969M
Gross margin
33.3%
Net margin
8.9%
DGX's operating income is up by 22% year-on-year and by 3.8% since the previous quarter
The gross profit has increased by 16% YoY and by 4% from the previous quarter
The net income has grown by 15% YoY and by 2% from the previous quarter
The revenue has grown by 14% YoY and by 3.1% from the previous quarter
Price vs fundamentals
How does DGX's price correlate with its fundamentals
Growth
What is Quest Diagnostics's growth rate over time
Valuation
What is Quest Diagnostics stock price valuation
P/E
20.63
P/B
2.75
P/S
1.84
EV/EBIT
16.79
EV/EBITDA
12.31
EV/Sales
2.38
DGX's price to earnings (P/E) is 31% higher than its 5-year quarterly average of 15.8
DGX's EPS is up by 15% year-on-year and by 2% since the previous quarter
Quest Diagnostics's equity has increased by 7% YoY
The stock's price to book (P/B) is 6% more than its 5-year quarterly average of 2.6
The revenue has grown by 14% YoY and by 3.1% from the previous quarter
The stock's price to sales (P/S) is 8% more than its 5-year quarterly average of 1.7 but 3.2% less than its last 4 quarters average of 1.9
Efficiency
How efficient is Quest Diagnostics business performance
DGX's return on sales is up by 7% year-on-year
DGX's ROE is up by 6% year-on-year
Quest Diagnostics's return on invested capital has increased by 3.9% QoQ and by 3.3% YoY
DGX's return on assets is up by 3.4% year-on-year
Dividends
What is DGX's dividend history
DPS
$3.15
Dividend yield
1.77%
Payout ratio
36.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Quest Diagnostics financials performed over time
The total assets is 82% greater than the total liabilities
Quest Diagnostics's quick ratio has decreased by 14% YoY but it has increased by 2.3% QoQ
The current ratio has decreased by 10% YoY but it has increased by 3.7% QoQ
Quest Diagnostics's debt is 12% lower than its equity
The company's debt to equity fell by 14% YoY
Quest Diagnostics's debt has decreased by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.